Opportunistic infections in HIV: Difference between revisions
From IDWiki
m (typo) |
(→: links) |
||
Line 36: | Line 36: | ||
* ''[[Pneumocystis jirovecii]]'' (CD4 <200) |
* ''[[Pneumocystis jirovecii]]'' (CD4 <200) |
||
** Preferred: TMP-SMX 1 DS or SS PO daily |
** Preferred: [[TMP-SMX]] 1 DS or SS PO daily |
||
** Alternate |
** Alternate |
||
*** TMP-SMX 1 DS PO three times weekly |
*** [[TMP-SMX]] 1 DS PO three times weekly |
||
*** Dapsone 100 mg PO daily or 50 mg PO BID |
*** [[Dapsone]] 100 mg PO daily or 50 mg PO BID |
||
*** Pentamidine nebs 300 mg every month |
*** [[Pentamidine]] nebs 300 mg every month |
||
*** Atovaquone 1500 mg PO daily |
*** [[Atovaquone]] 1500 mg PO daily |
||
* ''[[Toxoplasma gondii]]'' (CD4 <100 and IgG positive) |
* ''[[Toxoplasma gondii]]'' (CD4 <100 and IgG positive) |
||
** Preferred: TMP-SMX 1 DS PO daily |
** Preferred: [[TMP-SMX]] 1 DS PO daily |
||
** Alternate |
** Alternate |
||
*** TMP-SMX 1 DS PO three times weekly |
*** [[TMP-SMX]] 1 DS PO three times weekly |
||
*** TMP-SMX 1 SS PO daily |
*** [[TMP-SMX]] 1 SS PO daily |
||
*** Dapsone 50 mg PO daily + pyrimethamine/leucovorin PO weekly |
*** [[Dapsone]] 50 mg PO daily + pyrimethamine/leucovorin PO weekly |
||
*** Atovaquone 1500 mg PO daily |
*** [[Atovaquone]] 1500 mg PO daily |
||
* ''[[Mycobacterium avium complex]]'' (CD4 <50) |
* ''[[Mycobacterium avium complex]]'' (CD4 <50) |
||
** Preferred: Azithromycin 1200 mg PO once weekly |
** Preferred: [[Azithromycin]] 1200 mg PO once weekly |
||
** Alternate |
** Alternate |
||
*** Clarithromycin 500 mg PO BID |
*** [[Clarithromycin]] 500 mg PO BID |
||
*** Azithromycin 600 mg PO twice weekly |
*** [[Azithromycin]] 600 mg PO twice weekly |
||
*** Rifabutin, dose-adjusted to HIV meds |
*** [[Rifabutin]], dose-adjusted to HIV meds |
||
* [[Histoplasma capsulatum]] (CD4 <150 and high risk) |
* [[Histoplasma capsulatum]] (CD4 <150 and high risk) |
||
** "High risk" includes occupational exposure or residence in a community with a hyperendemic rate of histoplasmosis (>10 cases/100 patient-years) |
** "High risk" includes occupational exposure or residence in a community with a hyperendemic rate of histoplasmosis (>10 cases/100 patient-years) |
||
** Preferred: Itraconazole 200 mg PO once daily |
** Preferred: [[Itraconazole]] 200 mg PO once daily |
||
== Further Reading == |
== Further Reading == |
Revision as of 11:27, 21 November 2019
CD4 | Infections | Action |
---|---|---|
Any | Tuberculosis | Screen for latent tuberculosis Vaccinate for pneumococcus, influenza, varicella, HPV (if appropriate), Hepatitis A, and Hepatitis B |
<500 | Kaposi sarcoma (HHV-8) Herpes simplex Varicella zoster |
|
<300 | Candida Molluscum contagiosum Diarrhea from microsporidia and cryptosporidia |
|
<200 | Pneumocystis jirovecii pneumonia | Start PJP prophylaxis (Septra SS or DS) |
<150 | Dimorphic fungi | Start histoplasmosis prophylaxis if high risk (occupation or hyperendemic) (itra) |
<100 | Toxoplasmosis Cryptococcus |
Start toxo prophylaxis if IgG positive (Septra DS) |
<50 | Mycobacterium avium complex Cytomegalovirus, including retinitis Progressive multifocal leukoencephalopathy (PML) from JC virus |
Start MAC prophylaxis (azithromycin) |
Prophylaxis regimens
- Pneumocystis jirovecii (CD4 <200)
- Preferred: TMP-SMX 1 DS or SS PO daily
- Alternate
- TMP-SMX 1 DS PO three times weekly
- Dapsone 100 mg PO daily or 50 mg PO BID
- Pentamidine nebs 300 mg every month
- Atovaquone 1500 mg PO daily
- Toxoplasma gondii (CD4 <100 and IgG positive)
- Preferred: TMP-SMX 1 DS PO daily
- Alternate
- TMP-SMX 1 DS PO three times weekly
- TMP-SMX 1 SS PO daily
- Dapsone 50 mg PO daily + pyrimethamine/leucovorin PO weekly
- Atovaquone 1500 mg PO daily
- Mycobacterium avium complex (CD4 <50)
- Preferred: Azithromycin 1200 mg PO once weekly
- Alternate
- Clarithromycin 500 mg PO BID
- Azithromycin 600 mg PO twice weekly
- Rifabutin, dose-adjusted to HIV meds
- Histoplasma capsulatum (CD4 <150 and high risk)
- "High risk" includes occupational exposure or residence in a community with a hyperendemic rate of histoplasmosis (>10 cases/100 patient-years)
- Preferred: Itraconazole 200 mg PO once daily